NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/19/2024
Back to search
Official data from USPTO
VALERIO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VALERIO THERAPEUTICS
ST13
US500000097867242Class
5, 42, 44
Filing
97867242
Registration
7574311
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/03/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/31/2023
Registration date
11/19/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Foreign priority
Drawing code
4
Owner type
33
Owner location
PARIS, FR
Examiner
WU, KRISTEN ZAHNOW
Law office
M50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
V. T. (pessoa física)
ONXEO
Representatives
Ben Natter HAUG PARTNERS, LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of oncological diseases and related immune disorders; Biological preparations for use in medicinal tests for identifying and treating oncological diseasesinoculations being vaccinestreatment of oncological diseases; medicinal and biological preparations for pharmaceutical use for the treatment of oncological diseases and disorders; Anti-cancer drugs; Pharmaceutical compounds for treating cancer; Anti-cancer preparations; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for use in oncology; Immunoassay reagents for medical use; Pharmaceutical preparations for the treatment of immune system related diseases and disorders
Class 42
Scientificmedical and pharmaceutical research for the treatment of oncological diseases; research and development of pharmaceutical preparations in the field of oncological diseases and disorders; drug discovery services for the treatment of oncological and immune related diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others; Development of pharmaceutical preparations and medicines; Consultancy relating to pharmaceutical research and development; Pharmaceutical products development; Clinical research in the field of oncology; Provision of information and data relating to medical research and development of pharmaceutical products
Class 44
medical analysis services for cancer diagnosis and prognosis; Providing cancer screening services; Medical analysis services for the diagnosis of cancer
Publications
History of USPTO decisions and trademark events.
24 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
11/19/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
10/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
10/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/13/2024
GNRT
NON-FINAL ACTION E-MAILED
08/13/2024
CNRT
NON-FINAL ACTION WRITTEN
08/13/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2024
ALIE
ASSIGNED TO LIE
08/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/16/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/02/2024
GNRT
NON-FINAL ACTION E-MAILED
01/02/2024
CNRT
NON-FINAL ACTION WRITTEN
01/02/2024
DOCK
ASSIGNED TO EXAMINER
12/27/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/24/2023
NWAP
NEW APPLICATION ENTERED
04/04/2023
Continuous trademark protection
Get notified about every new filing that threatens VALERIO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.